These drugs were originally developed for Type 2 diabetes, but now, when paired with diet and exercise, they are widely used for weight management, generating both curiosity and concern among employers and plan sponsors
Experts point to several forces driving the falling prices: mounting pressure from the public and Congress on drugmakers pricing practices
For Canadian patients particularly, the conversation around medication dependency carries unique weight given our universal healthcare culture that emphasizes prevention and lifestyle
This will be accessible through insurance for qualifying patients but will also create regulatory pressure on the grey market
Key points to follow: Follow the IMP label or trial protocol for the exact storage temperature and BUD do not assume a temperature range or time window If no BUD is stated , treat the preparation as single-use and administer immediately after reconstitution
These "gray-market" drugs bypass FDA manufacturing and purity standards